Medrio
Medrio provides cloud-based electronic data capture (EDC) and eClinical software used to design, run, and manage clinical trials for biopharma, medical device, and contract research organizations, with a focus on decentralized and hybrid studies. Its platform supports study build, data collection, eConsent, and patient engagement, and it generates revenue through subscription licensing and related professional services.
- Revenue
- $50M - $250M
- Employees
- 201 - 1,000
- Founded
- 2005
- Headquarters
- San Francisco, United States of America
Medrio customers on Arbolus
Customers who reviewed Medrio
Seniority of Medrio customers
Most people who reviewed Medrio hold Director roles (57%), followed by C-Suite (32%) and Manager (11%).
- Director 57%
- C-Suite 32%
- Manager 11%
Customers sample
Employer names and spend open in the full report, along with the other 25 customers.
What 28 Arbolus experts think of Medrio
Overall sentiment: Positive
NPS responses range from 4 to 10, with a mean NPS in the mid-7s and a notable cluster of highly positive (9–10) responses among high-spend, long-tenured users. Renewal intent is strong in accounts with more than 1 year of implementation and significant spend, while pilot-phase and smaller users show greater uncertainty. Sentiment drivers include ease of use, regulatory compliance, and customer support, with negative feedback focused on reporting flexibility and pilot user satisfaction.
Everything 28 customers told us about Medrio.
Employer names, spend, renewal intent and every written answer behind the numbers on this page.
Sentiment
10 Net Promoter Score, from 28 scored reviews- Promoters 9
- Passives 13
- Detractors 6
Praised
- Improved Reporting
- Enterprise Upsell from Pilots
- AI-Driven Optimization
- Customer Support
Criticised
- Pilot User Preference for Alternatives
- Limited Reporting Flexibility
- Non-Critical for Advanced Trials
- Reliance on Rave EDC
What Medrio customers say
Customer Support
“One of Medrio’s main advantages for us has been customer support and the ease of developing studies compared to other tools.”
User-Friendliness
“Medrio is designed to let studies be built and modified relatively quickly and easily, without needing intense programming or technical skills.”
Purpose-Built Compliance
“Medrio offers a more complete infrastructure for clinical trials than RedCap, with strong compliance features like audit trails, data validation, and electronic signatures.”
Renewal intent
Plan to renew 67%Plan to renew, by seniority
- 88% 8 answers
- 44% 9 answers
- 100% 1 answer
- 8.8/10 Average score from customers who will renew
- 6.4/10 Average score from undecided customers
- 7/10 Average score from customers not renewing
Top alternatives
Most weighed by Medrio customersReport
For people who use Medrio
Do you use Medrio at work?
Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.
- 28 customers of Medrio have already contributed
Takes a few minutes. Your identity stays anonymous.